18271547. Polymer Films simplified abstract (FUJIFILM CORPORATION)

Polymer Films

Organization Name

FUJIFILM CORPORATION

Inventor(s)

Jacko Hessing of Tilburg (NL)

Elisa Huerta Martinez of Tilburg (NL)

Adrianus Jacobus Van Rijen of Tilburg (NL)

Renée Maria Ripken of Tilburg (NL)

Takeshi Narita of Tilburg (NL)

Polymer Films - A simplified explanation of the abstract

This abstract first appeared for US patent application 18271547 titled 'Polymer Films

Simplified Explanation

The patent application describes a polymer film containing anionic groups and specific amounts of two types of crosslinking agents, one of which is free from fluoro groups.

• The polymer film contains anionic groups and crosslinking agents.
• The crosslinking agents include one without fluoro groups and a non-ionic crosslinking agent.
• The crosslinking agent without fluoro groups has a specific chemical structure represented by Formula (I) in the patent application.
• The polymer film contains 0.008 to 25 mg/g of each of the crosslinking agents.

Potential Applications

The technology described in the patent application could have potential applications in:

• Biomedical devices
• Drug delivery systems
• Coatings for medical implants

Problems Solved

This technology addresses the following problems:

• Enhancing the stability and durability of polymer films
• Improving the performance of biomedical devices
• Increasing the efficiency of drug delivery systems

Benefits

The benefits of this technology include:

• Increased strength and flexibility of polymer films
• Enhanced biocompatibility for medical applications
• Controlled release of drugs from delivery systems

Potential Commercial Applications

The technology could be commercially applied in:

• Biomedical device manufacturing
• Pharmaceutical industry for drug delivery systems
• Coating industry for specialized applications

Possible Prior Art

One possible prior art could be the use of crosslinking agents in polymer films for various applications. However, the specific combination of anionic groups, non-fluoro crosslinking agents, and the unique structure of the crosslinking agent represented by Formula (I) may be novel and inventive.

How does this technology compare to existing polymer film formulations in terms of mechanical properties and biocompatibility?

The patent application does not provide a direct comparison with existing polymer film formulations in terms of mechanical properties and biocompatibility. Further research or testing would be needed to evaluate the performance of this technology against current standards.

What are the potential challenges in scaling up the production of polymer films using this technology for commercial applications?

The patent application does not address the potential challenges in scaling up the production of polymer films using this technology for commercial applications. Factors such as cost-effectiveness, scalability, and regulatory compliance could pose challenges that need to be explored in future development and implementation.

Original Abstract Submitted

A polymer film comprising anionic groups and 0.008 to 25 mg/g of each of components (a) and (b): (a) a crosslinking agent which is free from fluoro groups and comprises a group of Formula (I); and (b) a non-ionic crosslinking agent; Formula (I) wherein M is a cation and * indicates the attachment points to other elements of the crosslinking agent.